MedTrace Logo

Dry Needling for Treating Spasticity in Multiple Sclerosis

NCT05351957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-28

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). \[Participants and Methods\] participants with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Sta- tus Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement.

Conditions

Interventions

PROCEDURE

Dry needling

Only dry needling of the lower limbs will performed in all patients with acupunture needling

Sponsors & Collaborators

  • Hospital Universitario de Canarias

    lead OTHER

Principal Investigators

  • MONSERRAT GONZÁLEZ-PLATAS · Hospital Universitario de Canarias

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-18
Primary Completion
2020-04-20
Completion
2020-09-22

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05351957 on ClinicalTrials.gov